Enrofloxacin

Journal of Exotic Pet Medicine

Volumn 15, Issue 1, 2006, Pages 66-69

  Mitchell, Mark A ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33745921234     PISSN: 15575063     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jepm.2005.11.011     Document Type: Article

References (29)

1. Hooper D., and Wolfson J. The fluoroquinolones. structures, mechanisms of action and resistance and spectra of activity in vitro. Antimicrob Agents Chemotherap 28 (1985) 581-586
2. Vancutsem P.M., Babish J.G., and Schwark W.S. The fluoroquinolone antimicrobials. structure, antimicrobial activity, pharmacokinetics, clinical use in domestic animals and toxicity. Cornell Vet 80 (1990) 173-186
3. Scheer M. Studies on the antibacterial activity of Baytril®. Vet Med Review 2 (1987) 90-98
4. Parpia S., Nix D., Hejmanowski H., et al. Sucralfate reduces the gastrointestinal absorption of norfloxacin. Antimicrob Agents Chemotherap 33 (1989) 99-102
5. Montay G., Goueffon Y., and Roquet F. Absorption, distribution, metabolic fate, and elimination of pefloxacin mesylate in mice, rats, dogs, monkeys, and humans. Antimicrob Agents Chemotherp 25 (1984) 463-472
6. Oomori Y., Yasue T., Aoyama H., et al. Effects of fleroxacin on HeLa cell functions and topoisomerase II. J Antimicrob Chemotherap 22 suppl D (1988) 91-97
7. Hussy P., Maass G., Tummler B., et al. Effect of 4-quinolones and novobiocin on calf thymus DNA polymerase alpha primase complex, topoisomerases I and II, and growth of mammalian lymphoblasts. Antimicrob Agents Chemotherap 29 (1986) 1073-1078
8. Diver J.M., and Wise R. Morphological and biochemical changes in Escherichia coli after exposure to ciprofloxacin. J Antimicrob Chemotherap 18 suppl D (1986) 31-41
9. Easom C.S.F., and Crane J.P. Uptake of ciprofloxacin by human neutrophils. J Antimicrob Chemotherap 23 (1983) 284-288
10. Piddock L., and Wise R. Mechanisms of resistance to quinolones and clinical perspectives. J Antimicrob Therap 23 (1989) 475-481
11. Neu H.C. Bacterial resistance to fluoroquinolones. Rev Infect Dis 10 suppl D (1988) 57-63
12. Bellido F., and Pechere J.C. Laboratory survey of fluoroquinolone activity. Rev Infect Dis 11 suppl 5 (1989) 917-924
13. Kato M., and Onodera T. Morphological investigation of cavity formation in articular cartilage induced by ofloxacin in rats. Fund Applied Toxicol 11 (1988) 110-119
14. Burkhardt J., Hill M.A., Carlton W.W., et al. Histologic and histochemical changes in articular cartilages of immature beagle dogs dosed with difloxacin, a fluoroquinolone. Vet Pathol 27 (1990) 162-170
15. Bendele A.M., Hulman J.F., Harvey A.K., et al. Passive role of articular chondrocytes in quinolone induced arthropathy in guinea pigs. Toxicol Pathol 18 (1990) 304-312
16. Berg J. Clinical indications for enrofloxacin in domestic animals and poultry, in Quinolones: A Symposium: A new class of antimicrobial agents for use in veterinary medicine (1988), Mobay Corporation, Shawnee, KS 25-34
17. Schluter G. Ciprofloxacin. review of potential toxicologic effects. Am J Med 82 suppl 4A (1987) 91-93
18. Ball P. Ciprofloxacin. An overview of adverse experiments. J Antimicrob Chemotherap 18 suppl D (1986) 197-193
19. Spiecker R. Untersuchungen zur Wirksamkeit des Chinoloncarbonsaure derivats. Bay Vp 2674 bei der Behandlung der latenten Salmonellen Infektion des Rindes. Dissertation (1986), Tierartzliche Hochschule, Hannover, West-Germany
20. Bauditz R. Results of clinical studies with Baytril in calves and pigs. Vet Med Review 2 (1987) 122-129
21. Hungerford C., Spelman L., and Papich M.G. Pharmacokinetics of enrofloxacin after oral and intramuscular administration in Savannah monitors (Varanus exanthematicus) (1997), AAZV, Houston, TX 89-92 Proceedings of the American Association of Zoo Veterinarians, October 28-30, 1997
22. Young L.A., Schumacher J., Jacobson E., et al. Disposition of enrofloxacin and its metabolite ciprofloxacin after IM injection in Burmese pythons (Python molurus bivittatus). J Zoo Wildl Med 28 (1997) 71-79
23. Helmick K.E., Papich M.G., Vliet K.A., et al. Pharmacokinetics of enrofloxacin after single-doe oral and intravenous administration in the American alligator (Alligator mississipiensis). J Zoo Wildl Med 35 (2004) 333-340
24. Raphael B.L., Papich M., and Cook R.A. Pharmacokinetics of enrofloxacin after a single intramuscular injection in Indian star tortoises (Geochelone elegans). J Zoo Wildl Med 25 (1994) 88-94
25. Flammer K., Aucoin D.P., Whitt D.A., et al. Plasma concentrations of enrofloxacin in African grey parrots treated with medicated water. Avian Dis 34 (1990) 1017-1022
26. Harrenstein L.A., Tell L.A., Vulliet R., et al. Disposition of enrofloxacin in red-tailed hawks (Buteo jamaicensis) and great-horned owls (Bubo virginianus) after a single oral, intramuscular, or intravenous dose. J Avian Med Surg 14 (2000) 228-236
27. Broome R.L., Brooks D.L., Babish J.G., et al. Pharmacokinetic properties of enrofloxacin in rabbits. Am J Vet Res 52 (1991) 1835-1841
28. Aramayona J.J., Mora J., Fraile L.J., et al. Penetration of enrofloxacin and ciprofloxacin into breast milk, and pharmacokinetics of the drugs in lactating rabbits and neonatal offspring. Am J Vet Res 57 (1996) 547-553
29. Carpenter J.W. Exotic Animal Formulary. (ed 3). (2005), Elsevier Saunders, St. Louis, MO